Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5767994

COc1cc2c(C(=O)O)cnc(C(=O)c3cccc(OCC(=O)O)c3)c2cc1OC.O=C(O)C(F)(F)F

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GFPT1 Q06210 1/20 0.51
▸ LMNA P02545 1/20 0.44
▸ PKM P14618 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ PTPN1 P18031 1/20 0.40
▸ VNN1 O95497 2/20 0.39
▸ MRGPRX4 Q96LA9 1/20 0.38
▸ PDE10A Q9Y233 3/20 0.38
▸ APAF1 O14727 1/20 0.38
▸ NSD2 O96028 1/20 0.38
▸ CASP3 P42574 1/20 0.38
▸ SENP8 Q96LD8 1/20 0.38
▸ SENP7 Q9BQF6 1/20 0.38
▸ SENP6 Q9GZR1 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ NR1H2 P55055 2/20 0.37
▸ NR1H3 Q13133 2/20 0.37
▸ AURKB Q96GD4 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5745432 0.95 LMNA (0.48) GFPT1LMNAPKMHTTPTPN1
SCHEMBL5768004 0.88 GFPT1 (0.49) GFPT1LMNAPKMHTTPTPN1
Trifluoroacetic Acid SCHEMBL5809778 0.88 GFPT1 (0.46) GFPT1HTTL3MBTL1KDM4EMAPK1
Trifluoroacetic Acid SCHEMBL5768592 0.87 GFPT1 (0.63) GFPT1PDE10AAPAF1NSD2CASP3
Trifluoroacetic Acid SCHEMBL5793358 0.86 RAB9A (0.46) GFPT1VNN1L3MBTL1NR1H2NR1H3
Trifluoroacetic Acid SCHEMBL5763821 0.86 GAA (0.51) GFPT1HTTL3MBTL1MAPK1
SCHEMBL5744619 0.86 GFPT1 (0.49) GFPT1LMNAHTTPDE10AAPAF1
SCHEMBL5743512 0.86 GFPT1 (0.56) GFPT1LMNAPKMHTTPTPN1
Trifluoroacetic Acid SCHEMBL6107669 0.86 FKBP1A (0.45) GFPT1KDM4EMAPK1
SCHEMBL5743882 0.86 GFPT1 (0.49) GFPT1VNN1PDE10AAPAF1NSD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067529-B2 Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors HOFFMANN-LA ROCHE INC. (US) 2006-06-27 — — US disclosed
EP-1631551-A2 ISOQUINOLINE DERIVATIVES AND THEIR USE AS GFAT INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2006-03-08 — — EP disclosed
US-20040259910-A1 Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors BOLIN DAVID ROBERT (US) 2004-12-23 — — US disclosed
WO-2004101528-A2 ISOQUINOLINE DERIVATIVES AND THEIR USE AS GFAT INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2004-11-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259910-A1 Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors GFPT1, GLS2, GLS GFPT1 1/4885LMNA 4843/4885PKM 887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback